IDXX vs VKTX · P/E 40, rev $2.36B vs $3.97B cap
IDEXX Laboratories Inc (IDXX) versus Viking Therapeutics Inc (VKTX) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Viking Therapeutics Inc (VKTX) is a biotechnology company listed on US.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported VKTX revenue for 2026-06-30 was $0. Net income was -$286.3M. VKTX currently screens at market cap $3.97B.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. VKTX currently screens at market cap $3.97B.
Not investment advice. Open the IDXX and VKTX stock pages for the full models.
Not investment advice.